Mar 15 2019
Premier Health Group (the “Company” or “Premier Health”), a Company focused on developing innovative approaches that combine human skill-based expertise with emerging technologies for the healthcare industry, is pleased to announce it is working with Bio Conscious Technologies (BCT) to bring their Artificial Intelligence (AI) technology to Premier Health’s user base.
Premier Health will be partnering with BCT to enable patients and care providers improved monitoring of chronic disease progression and management of chronic conditions, such as diabetes, using BCT’s proprietary AI technology.
BCT has been developing an ensemble of AI algorithms since 2015 that allow patients with diabetes to better manage their health proactively by accurately predicting their future glucose levels using machine learning techniques. The World Health Organization estimates that 425 million people are living with diabetes. Mismanagement of diabetes can be very harmful. BCT’s algorithm, DiaBits, learns an individual’s physiology and predicts, with machine learning technology, where their blood sugar will trend over time based on their past trend, behaviour, and activity. BCT successfully piloted its technology at BC Children’s Hospital, resulting in a proven accuracy of 95%. They also presented at the 78th scientific session of the American Diabetes Association. The companies will work on integrating DiaBits into Premier Health’s patient-centric healthcare app.
Since the beginning, remote patient monitoring has been an integral component of our telemedicine app. DiaBits will enable our diabetic patients to dramatically increase glucose control and improve their quality of life. We are eager to work with the team at BCT to bring this innovative solution to our comprehensive telemedicine app.”
Dr. Essam Hamza, CEO of Premier Health
We are excited to be selected by Premier Health to partner for our remote health monitoring technology. Incorporating the DiaBits technology platform into Premier Health’s app will reduce the guesswork associated with managing diabetes and result in diabetic users having fewer sugar highs, and fewer sugar lows, all while delaying the onset of complications. We are also in the works for developing similar technologies that predict high blood-pressure and premature contractions for pregnant women at risk of pre-eclampsia.”
Amir Hayeri, CEO of BCT
Source: https://www.mypremierhealth.com/